|86.18||+4.45||+5.44%||Vol 110.26K||1Y Perf -5.65%|
|Jun 24th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||117.67||Analyst Rating||Strong Buy 1.29|
|Potential %||36.54||Finscreener Ranking||★★★+ 51.66|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★+ 54.32|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★ 57.41|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||44.54||Earnings Rating||Sell|
|Market Cap||1.38B||Earnings Date||1st Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|10 Years||1 695.42%|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||1st Aug 2022|
|Estimated EPS Next Report||0.80|
|EPS Growth Next 5 Years %||11.40|
|Avg. Weekly Volume||79.02K|
|Avg. Monthly Volume||60.89K|
|Avg. Quarterly Volume||73.16K|
Addus HomeCare Corporation (NASDAQ: ADUS) stock closed at 86.18 per share at the end of the most recent trading day (a 5.44% change compared to the prior day closing price) with a volume of 110.26K shares and market capitalization of 1.38B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 33238 people. Addus HomeCare Corporation CEO is R. Dirk Allison.
The one-year performance of Addus HomeCare Corporation stock is -5.65%, while year-to-date (YTD) performance is -7.84%. ADUS stock has a five-year performance of 131.67%. Its 52-week range is between 68.57 and 108.11, which gives ADUS stock a 52-week price range ratio of 44.54%
Addus HomeCare Corporation currently has a PE ratio of 28.00, a price-to-book (PB) ratio of 2.13, a price-to-sale (PS) ratio of 1.41, a price to cashflow ratio of 19.60, a PEG ratio of 2.32, a ROA of 4.92%, a ROC of 5.92% and a ROE of 8.23%. The company’s profit margin is 5.03%, its EBITDA margin is 9.30%, and its revenue ttm is $885.83 Million , which makes it $55.12 revenue per share.
Of the last four earnings reports from Addus HomeCare Corporation, there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $0.80 for the next earnings report. Addus HomeCare Corporation’s next earnings report date is 01st Aug 2022.
The consensus rating of Wall Street analysts for Addus HomeCare Corporation is Strong Buy (1.29), with a target price of $117.67, which is +36.54% compared to the current price. The earnings rating for Addus HomeCare Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Addus HomeCare Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Addus HomeCare Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 15.14, ATR14 : 3.21, CCI20 : 100.43, Chaikin Money Flow : 0.08, MACD : -0.74, Money Flow Index : 51.22, ROC : 2.95, RSI : 60.05, STOCH (14,3) : 98.89, STOCH RSI : 1.00, UO : 64.55, Williams %R : -1.11), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Addus HomeCare Corporation in the last 12-months were: Brian Poff (Sold 2 059 shares of value $160 781 ), Darby Anderson (Option Excercise at a value of $39 676), Darby Anderson (Sold 5 651 shares of value $554 896 ), David W. Tucker (Sold 1 207 shares of value $103 379 ), Michael D. Wattenbarger (Option Excercise at a value of $39 375), Michael D. Wattenbarger (Sold 3 647 shares of value $313 906 ), Monica Raines (Sold 190 shares of value $15 607 ), R. Dirk Allison (Sold 8 009 shares of value $612 788 ), Robertson James Stevenson (Sold 137 shares of value $11 121 ), Sean Gaffney (Sold 1 554 shares of value $122 885 ), W. Bradley Bickham (Sold 1 865 shares of value $141 779 )
Thu, 10 Mar 2022 12:40 GMT Analysts Top Healthcare Picks: Addus Homecare (ADUS), Amryt Pharma (AMYT)- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.